Mr. Howard E. Greene Jr.

• 
  www.sec.gov/Archives/edgar/data/881464/0001047469-08-00 - [Cached Version]
  Published on: 4/25/2008    Last Visited: 4/26/2008  

  Accordingly, there are twelve nominees for director this year: Adrian Adams, Steven R. Altman; Teresa Beck; Daniel M. Bradbury; Joseph C. Cook, Jr.; Karin Eastham; James R. Gavin III; Ginger L. Graham; Howard E. Greene, Jr.; Jay S. Skyler; Joseph P. Sullivan; and James N. Wilson.
  ...
  Howard E. Greene, Jr.
  ...
  Mr. Greene is our co-founder and has served as a director since our inception in 1987.Mr. Greene serves on the Finance Committee.Mr. Greene is an entrepreneur who has participated in the founding and/or management of eleven medical technology companies over two decades, including three companies for which he served as chief executive officer.From 1987 to 1996, Mr. Greene served as our Chief Executive Officer.From 1986 until 1993, Mr. Greene was a founding general partner of Biovest Partners, a seed venture capital firm.He was Chief Executive Officer of Hybritech from 1979 until its acquisition by Eli Lilly and Company in 1986, and he was co-inventor of Hybritech's patented monoclonal antibody assay technology.Prior to joining Hybritech, he was an executive with the medical diagnostics division of Baxter Healthcare Corporation from 1974 to 1979 and a consultant with McKinsey & Company from 1967 to 1974.He is a director of Biosite Incorporated.Mr. Greene received an M.B.A. from Harvard University.
  ...
  Consistent with these considerations, after review of all relevant transactions or relationships between each director, or any of his or her family members, and Amylin, our senior management and our independent auditors, our Board of Directors has affirmatively determined that each of Mr. Adams, Mr. Altman, Ms. Beck, Ms. Eastham, Dr. Gavin, Mr. Greene, Dr. Skyler, Mr. Sullivan and Mr. Wilson are independent directors within the meaning of the applicable NASDAQ listing standards.

• 
  www.sec.gov/Archives/edgar/data/822206/0000950134-05-01 - [Cached Version]
  Published on: 6/23/2005    Last Visited: 3/24/2006  

  Howard E. ("Ted") Greene, Jr.
  ...
  Mr. Greene, a founder of Epimmune, has served as a director since our inception.He was elected Chairman of the Board in January 1989 and served as President from July 1987 to January 1989.Mr. Greene is a director and founder of Amylin Pharmaceuticals, Inc., a biotechnology company involved in research and development of medicines for treating diabetes and served as Chairman of the Board from 1987 to 1998.He was a general partner of Biovest Partners, a seed venture capital firm specializing in medical technology companies from 1986 until 1993.Prior to Biovest, he was Chief Executive Officer of Hybritech Incorporated, a biotechnology company acquired by Eli Lilly & Company in 1986.Mr. Greene is a director of Amylin and Biosite Incorporated.

• 
  www.sec.gov/Archives/edgar/data/881464/0000936392-01-50 - [Cached Version]
  Published on: 4/5/2001    Last Visited: 9/15/2001  

  Howard E. Greene , Jr. ( 2 ) ( 3 )Member , Board of Directors
  
  ...
  Mr. Greene is a co-founder of Amylin and has served as a director since our inception in September 1987.Mr. Greene serves on the Audit and Nominating Committees.Mr. Greene is an entrepreneur who has participated in the founding and/or management of eleven medical technology companies over a 22 year period , including three as Chief Executive Officer.From September 1987 to July 1996 Mr. Greene served as our Chief Executive Officer.He was a full time employee of Amylin from September 1989 until September 1996 , and a half-time employee and Chairman of the Executive Committee until March 1998.From October 1986 until July 1993 , Mr. Greene was a founding general partner of Biovest Partners , a seed venture capital firm.He was Chief Executive Officer of Hybritech from March 1979 until its acquisition by Eli Lilly & Company in March 1986 , and he was co-inventor of Hybritech's patented monoclonal antibody assay technology.Prior to joining Hybritech , he was an executive with the medical diagnostics division of Baxter Healthcare Corporation from 1974 to 1979 and a consultant with McKinsey & Company from 1967 to 1974.He is Chairman of the Board of Epimmune , Inc. , and a director of Biosite Diagnostics , Inc. and The International Biotechnology Trust plc , a British Investment company.Mr. Greene received an M.B.A. from Harvard University.

• 
  www.sec.gov/Archives/edgar/data/903574/0001367982-08-00 - [Cached Version]
  Published on: 7/7/2008    Last Visited: 7/8/2008  

  0000903574 GREENE HOWARD E JR 9360 TOWNE CENTRE DR SAN DIEGO CA 92121 1 0 0 0

• 
  www.signonsandiego.com/news/metro/20080914-9999-1m14bio - [Cached Version]
  Published on: 9/14/2008    Last Visited: 9/14/2008  

  Happy hour started at 4 p.m. on Fridays, with cheap beer on tap in the cafeteria, said Ted Greene, Hybritech's early president.
  
  "Our TGIF was legendary," Greene said, pausing to exclaim about the number of white and bald heads coming through the door at the 30th Hybritech reunion yesterday in Carmel Valley.About 350 former employees came from as far as France.
  
  Greene is one of only two guys wearing ties in a 1979 staff photo that was enlarged and mounted on an easel at the reunion.
  ...
  Greene and Birndorf, both considerably more corporate-looking now in polo shirts and slacks, have launched several other successful start-ups since then.
  ...
  We were trying to solve a mystery of what can be done," Greene said.
  ...
  Greene is retired but remains on the board of Amylin Pharmaceuticals, which he founded.
  ...
  Greene addressed the boisterous crowd, telling them his name was on the letterhead, but they did the work that made Hybritech a local legend.
  
  "For a company that hasn't existed for 20 years, that's something pretty powerful," he said.

• 
  www.investorvillage.com/smbd.asp?mb=2885&mn=38278&pt=ms - [Cached Version]
  Published on: 12/27/2007    Last Visited: 12/28/2007  

  Howard E. (Ted) Greene, Jr.Cofounder, Amylin Pharmaceuticals, Inc.
  
  Mr. Greene is our co-founder and has served as a director since our inception in 1987.Mr. Greene serves on the Finance Committee.Mr. Greene is an entrepreneur who has participated in the founding and/or management of eleven medical technology companies over two decades, including three companies for which he served as chief executive officer.From 1987 to 1996, Mr. Greene served as our Chief Executive Officer.From 1986 until 1993, Mr. Greene was a founding general partner of Biovest Partners, a seed venture capital firm.He was Chief Executive Officer of Hybritech from 1979 until its acquisition by Eli Lilly and Company in 1986, and he was co-inventor of Hybritech's patented monoclonal antibody assay technology.Prior to joining Hybritech, he was an executive with the medical diagnostics division of Baxter Healthcare Corporation from 1974 to 1979 and a consultant with McKinsey & Company from 1967 to 1974.He is also a board member of Biosite Incorporated.Mr. Greene received an M.B.A. from Harvard University.

• 
  www.sec.gov/Archives/edgar/data/834306/0000903574-07-00 - [Cached Version]
  Published on: 6/25/2007    Last Visited: 6/27/2007  

  0000903574 GREENE HOWARD E JR BIOSITE INCORPORATED 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 1 0 0 0

• 
  www.directorsforum.com/DOY08/past_honorees.html - [Cached Version]
  Published on: 1/1/1991    Last Visited: 4/1/2008  

  Howard "Ted" Greene, Jr.Amylin Corp

• 
  www.sec.gov/Archives/edgar/data/881464/0001104659-07-02 - [Cached Version]
  Published on: 4/13/2007    Last Visited: 4/20/2007  

  There are eleven nominees for director this year: Steven R. Altman; Teresa Beck; Daniel M. Bradbury; Joseph C. Cook, Jr.; Karin Eastham; James R. Gavin III; Ginger L. Graham; Howard E. Greene, Jr.; Jay S. Skyler; Joseph P. Sullivan; and James N. Wilson.
  ...
  Howard E. Greene, Jr.
  ...
  Mr. Greene is our co-founder and has served as a director since our inception in 1987.Mr. Greene serves on the Finance Committee.Mr. Greene is an entrepreneur who has participated in the founding and/or management of eleven medical technology companies over two decades, including three companies for which he served as chief executive officer.From 1987 to 1996, Mr. Greene served as our Chief Executive Officer.From 1986 until 1993, Mr. Greene was a founding general partner of Biovest Partners, a seed venture capital firm.He was Chief Executive Officer of Hybritech from 1979 until its acquisition by Eli Lilly and Company in 1986, and he was co-inventor of Hybritech's patented monoclonal antibody assay technology.Prior to joining Hybritech, he was an executive with the medical diagnostics division of Baxter Healthcare Corporation from 1974 to 1979 and a consultant with McKinsey & Company from 1967 to 1974.He is a director of Biosite Incorporated.Mr. Greene received an M.B.A. from Harvard University.
  ...
  Consistent with these considerations, after review of all relevant transactions or relationships between each director, or any of his or her family members, and Amylin, our senior management and our independent auditors, our Board of Directors has affirmatively determined that each of Mr. Altman, Ms. Beck, Mr. Bryson, Ms. Eastham, Dr. Gavin, Mr. Greene, Dr. Skyler, Mr. Sullivan, Mr. Testman and Mr. Wilson are independent directors within the meaning of the applicable NASDAQ listing standards.

• 
  www.sec.gov/Archives/edgar/data/834306/0001193125-07-08 - [Cached Version]
  Published on: 4/13/2007    Last Visited: 4/20/2007  

  Howard E. Greene, Jr.
  ...
  Howard E. Greene, Jr. joined the Biosite Board in June 1989.Mr. Greene is an entrepreneur who founded, managed and financed a series of medical technology companies during the past 25 years.From September 1987 to July 1996, Mr. Greene was the founding Chief Executive Officer of Amylin Pharmaceuticals, Inc., a biotechnology company developing drug candidates for treating metabolic diseases.From October 1986 until July 1993, Mr. Greene was a founding general partner of Biovest Partners, a seed venture capital firm.He was Chief Executive Officer of Hybritech Incorporated from March 1979 until its acquisition by Eli Lilly & Co. in March 1986, and was co-inventor of Hybritech's patented monoclonal antibody assay technology.Prior to joining Hybritech, he was an executive with the medical diagnostics division of Baxter Healthcare Corporation from 1974 to 1979, and a consultant with McKinsey & Company from 1967 to 1974.He is a director of Amylin Pharmaceuticals, Inc.Mr. Greene received a B.A. from Amherst College and an M.B.A. from Harvard University.
  ...
  Wollaeger (Chair), Greene and Smith.

Page:  1 2 3 4 5